Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
Multi-center observational study to assess the short-term response of multiple sclerosis (MS) patients initiated on Ozanimod with respect to fatigue. Patterns of brain changes on brain magnetic resonance imaging (MRI) that might modulate the effect of Ozanimod treatment on fatigue will also be assessed.
Epistemonikos ID: 50d0facc0f489c561e6a4c68bacce75853a15c5e
First added on: Oct 02, 2023